The Hon. (Dr.) Nalinda Jayatissa - Minister of Health and Mass Media and Chief Government Whip
The Minister provided data on the number of drug varieties manufactured by the State Pharmaceuticals Manufacturing Corporation from 2020 to 2025, noting that detailed lists and sales information were tabled in the Library. He stated that SPMC does not sell medicines below production cost, that private market prices are set with a margin at the time of manufacture, and that no losses had occurred from below-cost sales.
Verbatim record (translated)
Machine-translated from Sinhala / Tamil / English¶ 01 (a) (i) The numbers of drug varieties manufactured by SPMC are as follows (full names in Annexes 1-6 laid in the Library): - 2020: 49 - 2021: 49 - 2022: 58 - 2023: 59 - 2024: 53 - 2025: 55
¶ 02 (ii) SPMC does not sell below production cost. Prices to private market are set to ensure a margin at time of manufacture. Details of prices and quantities sold to private market from 2020-2025 are in Annexes 7-12 (laid in the Library).
¶ 03 (iii) No loss has occurred from below-cost sales.
¶ 04 (iv) Does not arise.
¶ 05 (b) Does not arise.
Provenance
- Source
- Hansard, Thursday, 19 February 2026 ·No. 23328 ·English daily/uncorrected Hansard
- Page · column
- not yet extracted — page/column anchors are not in the current dataset; the source PDF is the citable location.
- Permalink
/lk/speeches/30261
Cite as: The Hon. (Dr.) Nalinda Jayatissa - Minister of Health and Mass Media and Chief Government Whip. 10th Parliament, Parliament of Sri Lanka. Hansard, 19 February 2026. No. 23328. Politick, https://staging.politick.io/lk/speeches/30261